PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

27 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Krause, J.* et al.: An arrhythmogenic metabolite in atrial fibrillation. J. Transl. Med. 21:566 (2023)
2.
Schmitz, T.* et al.: Inflammatory plasma proteins predict short-term mortality in patients with an acute myocardial infarction. J. Transl. Med. 20:457 (2022)
3.
Harman, N.L.* et al.: Can harmonisation of outcomes bridge the translation gap for pre-clinical research? A systematic review of outcomes measured in mouse models of type 2 diabetes. J. Transl. Med. 18:468 (2020)
4.
Körber, N. ; Behrends, U. ; Protzer, U. & Bauer, T.: Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting. J. Transl. Med. 18:242 (2020)
5.
Bao, X. ; Anastasov, N. ; Wang, Y.* & Rosemann, M.: A novel epigenetic signature for overall survival prediction in patients with breast cancer. J. Transl. Med. 17:380 (2019)
6.
Wen, W.* et al.: Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma. J. Transl. Med. 17:186 (2019)
7.
Gary, R.* et al.: Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts. J. Transl. Med. 16:124 (2018)
8.
Slotta-Huspenina, J.* et al.: Correction: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus [J Transl Med., 16, (2018) (109)] DOI: 10.1186/s12967-018-1492-9. J. Transl. Med. 16:128 (2018)
9.
Halama, A.* et al.: Measurement of 1,5-anhydroglucitol in blood and saliva: From non-targeted metabolomics to biochemical assay. J. Transl. Med. 14:140 (2016)
10.
Körber, N. ; Behrends, U. ; Hapfelmeier, A.* ; Protzer, U. & Bauer, T.: Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring. J. Transl. Med. 14:175 (2016)
11.
Halama, A.* et al.: Metabolic signatures differentiate ovarian from colon cancer cell lines. J. Transl. Med. 13:223 (2015)
12.
Grabe, H.J.* et al.: Cohort profile: Greifswald approach to individualized medicine (GANI_MED). J. Transl. Med. 12:144 (2014)
13.
Mathew, S.* et al.: Metabolomics of Ramadan fasting: An opportunity for the controlled study of physiological responses to food intake. J. Transl. Med. 12:161 (2014)
14.
Roehnisch, T.* et al.: Phage idiotype vaccination: First phase I/II clinical trial in patients with multiple myeloma. J. Transl. Med. 12:119 (2014)
15.
Buhmann, R. et al.: Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: Study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating phase I/II-trial. J. Transl. Med. 11:160 (2013)
16.
Roehnisch, T.* et al.: Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model. J. Transl. Med. 11:267 (2013)
17.
Ruf, P.* et al.: Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model. J. Transl. Med. 10:219 (2012)
18.
Spranger, S. ; Frankenberger, B. & Schendel, D.J.: NOD/scid IL-2Rgnull mice: A preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo. J. Transl. Med. 10:30 (2012)
19.
Beck, B.* et al.: Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission. J. Transl. Med. 9:151 (2011)
20.
Fox, B.A.* et al.: Defining the critical hurdles in cancer immunotherapy. J. Transl. Med. 9:214 (2011)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮